ERBB2 and breast carcinoma: Several antigens for example, eIF-4 gamma in lung cancer (Brass et al. 1997) and HER-2/neu in breast cancer (Scanlan et al. 2001), which are overexpressed and have mounted an immune response, have been identified by SEREX.